HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease].

Abstract
Best's disease is an autosomal-dominant macular dystrophy, which might lead to choroidal neovascularization. The case of a 9-year-old boy followed up for a Best's disease is hereby reported. The boy was referred to our service department for a decrease in visual acuity in his right eye. Ophthalmoscopic examination revealed a foveolar vitelliform lesion, complicated by a choroidal neovascularization. The patient received a single intravitreal bevacizumab injection, which led to a complete resolution of intraretinal fluid and a significant reduction in neovascularization size. Visual acuity also improved. This case underlines the efficiency efficacy of intravitreal anti-VEGF therapy for choroidal neovascularization in Best's disease.
AuthorsJ Perol, B Wolff, J-A Sahel, Y Le Mer
JournalJournal francais d'ophtalmologie (J Fr Ophtalmol) Vol. 34 Issue 5 Pg. 281-6 (May 2011) ISSN: 1773-0597 [Electronic] France
Vernacular TitleTraitement par injection intravitréenne de bevacizumab de néovaisseaux choroïdiens compliquant une maladie de Best.
PMID21507509 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2011 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
Topics
  • Angiogenesis Inhibitors (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Child
  • Choroidal Neovascularization (diagnostic imaging, drug therapy, etiology)
  • Fluorescein Angiography
  • Genes, Dominant
  • Humans
  • Intravitreal Injections
  • Male
  • Pedigree
  • Radiography
  • Retinal Detachment (etiology)
  • Retinal Hemorrhage (etiology)
  • Tomography, Optical Coherence
  • Visual Acuity
  • Vitelliform Macular Dystrophy (complications, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: